Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Monoclonal Antibodies In Veterinary Health Market to reach USD 1.77 billion by the end of 2029

Global Monoclonal Antibodies In Veterinary Health Market Size study & Forecast, by Animal Type (Dogs, Others), by Application (Dermatology, Pain, Others), by End-User (Veterinary Hospitals, Others) and Regional Analysis, 2022-2029

Product Code: HLSHS-87377160
Publish Date: 8-10-2022
Page: 200

Global Monoclonal Antibodies In Veterinary Health Market is valued at approximately USD 0.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.7% over the forecast period 2022-2029. A monoclonal antibody is a type of antibody that is created by cloning a unique white blood cell. Monoclonal antibodies have a monovalent affinity that binds only to the same epitope. Monoclonal antibodies in veterinary health help in binding mono specifically to certain cells or proteins, imitating the animal’s natural response to attack those cells. Factors such as the growing pet population, and increasing expenditure on a pet, coupled with the rising incidences of canine atopic dermatitis are driving the market growth across the globe.

According to the Insurance Information Institute, in 2018, the total expenditure on the pet industry was estimated to account for USD 90.5 billion and the amount is constantly increasing and reached nearly USD 123.6 billion in 2021. Therefore, the increasing expenditure on a pet is leveraging the growth of Monoclonal Antibodies In Veterinary Health Market. In addition, an increasing number of initiatives by government and various private organizations, as well as growing investment in R&D activities are creating various growth prospects for the market development over the forecasting years. However, the lack of awareness and several problems associated with the Monoclonal Antibodies are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Monoclonal Antibodies In Veterinary Health Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the increasing expenditure on animal healthcare, rising number of veterinary clinics and hospitals, and the presence of leading companies. Moreover, Asia Pacific is expected to grow significantly during the forecast period. Factors such as the rising awareness regarding animal healthcare, rising prevalence of diseases in animals, along with the availability of treatment alternatives are bolstering the market demand across the region.

Major market players included in this report are:
Zoetis
Merck & Co, Inc.
Elanco Animal Health
Phibro Animal Health Corporation
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Virbac
American Animal Health, Inc.
Hester Biosciences Limited
Colorado Serum Company

Recent Developments in the Market:
 in January 2022, Zoetis publicized that its Solensia a product for pain management of osteoarthritis in cats has received the U.S. FDA approval.
 In January 2022, Boehringer Ingelheim International GmbH declared the company’s collaboration with MabGenesis, with the objective of developing monoclonal antibodies for canine diseases.
Global Monoclonal Antibodies In Veterinary Health Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Animal Type, Application, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Animal Type:
Dogs
Others
By Application:
Dermatology
Pain
Others
By End User:
Veterinary Hospitals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Monoclonal Antibodies In Veterinary Health Market, by Region, 2019-2029 (USD Billion)
1.2.2. Monoclonal Antibodies In Veterinary Health Market, by Animal Type, 2019-2029 (USD Billion)
1.2.3. Monoclonal Antibodies In Veterinary Health Market, by Application, 2019-2029 (USD Billion)
1.2.4. Monoclonal Antibodies In Veterinary Health Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Monoclonal Antibodies In Veterinary Health Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Monoclonal Antibodies In Veterinary Health Market Dynamics
3.1. Monoclonal Antibodies In Veterinary Health Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing pet population
3.1.1.2. Increasing expenditure on pet
3.1.2. Market Challenges
3.1.2.1. Lack of awareness
3.1.2.2. Several problems are associated with the Monoclonal Antibodies
3.1.3. Market Opportunities
3.1.3.1. Increasing number of initiatives by government and various private organizations
3.1.3.2. Growing investment in the R&D activities
Chapter 4. Global Monoclonal Antibodies In Veterinary Health Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Monoclonal Antibodies In Veterinary Health Market, by Animal Type
6.1. Market Snapshot
6.2. Global Monoclonal Antibodies In Veterinary Health Market by Animal Type, Performance – Potential Analysis
6.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by Animal Type, 2019-2029 (USD Billion)
6.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
6.4.1. Dogs
6.4.2. Others
Chapter 7. Global Monoclonal Antibodies In Veterinary Health Market, by Application
7.1. Market Snapshot
7.2. Global Monoclonal Antibodies In Veterinary Health Market by Application, Performance – Potential Analysis
7.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
7.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
7.4.1. Dermatology
7.4.2. Pain
7.4.3. Others
Chapter 8. Global Monoclonal Antibodies In Veterinary Health Market, by End-User
8.1. Market Snapshot
8.2. Global Monoclonal Antibodies In Veterinary Health Market by End-User, Performance – Potential Analysis
8.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
8.4.1. Veterinary Hospitals
8.4.2. Others
Chapter 9. Global Monoclonal Antibodies In Veterinary Health Market, Regional Analysis
9.1. Monoclonal Antibodies In Veterinary Health Market, Regional Market Snapshot
9.2. North America Monoclonal Antibodies In Veterinary Health Market
9.2.1. U.S. Monoclonal Antibodies In Veterinary Health Market
9.2.1.1. Animal Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Monoclonal Antibodies In Veterinary Health Market
9.3. Europe Monoclonal Antibodies In Veterinary Health Market Snapshot
9.3.1. U.K. Monoclonal Antibodies In Veterinary Health Market
9.3.2. Germany Monoclonal Antibodies In Veterinary Health Market
9.3.3. France Monoclonal Antibodies In Veterinary Health Market
9.3.4. Spain Monoclonal Antibodies In Veterinary Health Market
9.3.5. Italy Monoclonal Antibodies In Veterinary Health Market
9.3.6. Rest of Europe Monoclonal Antibodies In Veterinary Health Market
9.4. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Snapshot
9.4.1. China Monoclonal Antibodies In Veterinary Health Market
9.4.2. India Monoclonal Antibodies In Veterinary Health Market
9.4.3. Japan Monoclonal Antibodies In Veterinary Health Market
9.4.4. Australia Monoclonal Antibodies In Veterinary Health Market
9.4.5. South Korea Monoclonal Antibodies In Veterinary Health Market
9.4.6. Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market
9.5. Latin America Monoclonal Antibodies In Veterinary Health Market Snapshot
9.5.1. Brazil Monoclonal Antibodies In Veterinary Health Market
9.5.2. Mexico Monoclonal Antibodies In Veterinary Health Market
9.6. Rest of The World Monoclonal Antibodies In Veterinary Health Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Zoetis
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck & Co, Inc.
10.2.3. Elanco Animal Health
10.2.4. Phibro Animal Health Corporation
10.2.5. Boehringer Ingelheim GmbH
10.2.6. Indian Immunologicals Ltd
10.2.7. Virbac
10.2.8. American Animal Health, Inc.
10.2.9. Hester Biosciences Limited
10.2.10. Colorado Serum Company
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now